Bangkok Dusit Medical Services (BDMS) Earnings Surpass Expectations in 2Q with 3.49 Billion Baht Net Income

Bangkok Dusit Medical Services on Smartkarma

Analyst coverage on Smartkarma reveals insights into Bangkok Dusit Medical Services (BDMS TB). In the report titled “Bangkok Dusit Medical Services (BDMS TB): 1Q25 Stable; Resurgent Covid Might Scar 2Q” by Tina Banerjee, it is highlighted that BDMS saw a 6% revenue growth in 1Q25 driven by international and Thai patient revenue. Despite facing short-term challenges due to a COVID surge in Thailand, the company showed positive financial performance with EBITDA growing at 7% and net profit rising by 7%. Margins also expanded, emphasizing the importance of stable inpatient revenue growth and healthy occupancy for long-term success.

Another report by Tina Banerjee, “Bangkok Dusit Medical (BDMS TB): Stable 2024 Performance as International Patients Drive Growth“, details a 7% revenue growth in 2024 for BDMS from hospital operations, with strong contributions from both international and Thai patients. EBITDA and net profit increased as well, fueled by higher revenues and effective cost management strategies. The report also highlights the significant role of Centers of Excellence (COEs) in areas such as trauma, heart, orthopedics, cancer, and neuro, which contributed substantially to hospital revenue and EBITDA in 2024.

A look at Bangkok Dusit Medical Services Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts using Smartkarma Smart Scores to evaluate Bangkok Dusit Medical Services have provided a positive long-term outlook for the company. With strong scores in growth, resilience, and momentum, the company seems well-positioned for future success. Bangkok Dusit Medical Services, operating Bangkok General Hospital, focuses on specialized medical services including cardiovascular, lung, neurological, and cancer treatments, as well as physical therapy and medical imaging.

The company’s Smart Scores indicate favorable performance metrics in key areas such as growth potential, resilience to market fluctuations, and positive momentum. While the value score is relatively lower, the overall outlook suggests a promising trajectory for Bangkok Dusit Medical Services in the long term. Investors may find this company appealing for its potential growth prospects and resilience in the competitive healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma